Co-Authors
This is a "connection" page, showing publications co-authored by Jovana Milic and Alessandro Cozzi-Lepri.
Connection Strength
0.284
-
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
Score: 0.058
-
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. Clin Microbiol Infect. 2021 Aug; 27(8):1137-1144.
Score: 0.058
-
Tocilizumab in COVID-19: finding the optimal route and dose - Authors' reply. Lancet Rheumatol. 2020 Dec; 2(12):e739-e740.
Score: 0.056
-
Tocilizumab for severe COVID-19 pneumonia - Authors' reply. Lancet Rheumatol. 2020 Nov; 2(11):e660-e661.
Score: 0.056
-
Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e474-e484.
Score: 0.056